Luna Diabetes Announces Start of Pivotal Study to Bring Automated Insulin Delivery to Insulin Pens
Luna Diabetes announces the start of its pivotal trial for the Luna System today. Luna is the first automated insulin delivery solution intended for the >90% of all people with insulin-requiring diabetes who take their insulin with an insulin pen, commonly called multiple daily injections (MDI). The first-of-its-kind study will be the first to evaluate closed-loop technology in people on MDI in a pivotal study. The AID4MDI study will use...
Read more








